Status:

COMPLETED

Outcomes of Anti-HIV Therapy During Early HIV Infection

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Eligibility:

All Genders

13+ years

Brief Summary

The purpose of this study is to find out if it is effective to give aggressive anti-HIV therapy to patients who have been infected recently with HIV. Many doctors recommend that patients who have rec...

Detailed Description

Although many researchers have recommended initiation of aggressive antiretroviral therapy as soon as possible after HIV infection occurs, the tolerability and efficacy of this approach has not been s...

Eligibility Criteria

Inclusion Criteria

Patients may be eligible for this study if they:

  • Are at least 13 years old.
  • Have acute or early HIV infection. The stage of HIV infection will depend on the results from certain lab tests.

Exclusion Criteria

Patients will not be eligible for this study if they:

  • Are pregnant or breast-feeding.

Key Trial Info

Start Date :

October 1 1999

Trial Type :

OBSERVATIONAL

End Date :

June 1 2007

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00001093

Start Date

October 1 1999

End Date

June 1 2007

Last Update

October 29 2012

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Cedars Sinai Med Ctr

Los Angeles, California, United States, 90048

2

UCSD

San Diego, California, United States, 92103

3

San Francisco Gen Hosp / UCSF AIDS Program

San Francisco, California, United States, 94110